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Cutaneous Infection due to Mycobacterium abscessus 
A Case Report 
M. T. E. VOGELS1 , V. C. G. TJAN-HEJJNEN2 , J. A. C. ALKEMADE ·l, L. V. A.M. B EEX2 and H . L. MUYTJENSt 
Deparrmenl,\ of 'Medical Microbiology. 2Endocrinology. and 3Dermmology. Unil•ersiry HospiTal Nijmegen, The Netherland~ 
Erythematous nodular and ulcerating skin lesions occurred in a 
56-year-old woman treated with chemotherapy and glucocortico-
steroids for metas tatic breast cancer. Subsequent culture yielded 
Mycobacterium ahscessus, a facultative pathogen which e-xists 
as a saprophyte in the environment and rarely produces clinkal 
disease in humans. This organism is usually relatively resistant 
to antituberculous as well as a number of other antimicrobial 
agents. On the basis of in ~·itro susceptibility results, treatment 
with clarithromycin and clofazimine was installed and resolution 
of the lesions initiated. 
This report emphasizes once again that one should investigate 
any new or unusual skin lesions in immunocompromised patients 
by histology and culture of biopsies, including cultures for acid-
fast organisms. Key word: immunocompromised pntie11t. 
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Non tuberculous (atypical or environmental) mycobacteria 
have long remained in the shadow of M. tuberculosis, M. bol'is 
and M. leprae. But partially because of growing numbers of 
immunocompromised patients, these facu ltative pathogens are 
now enjoying increased interest. 
kf. abscessus is widespread in soil. dust and water and may 
be found as a contaminant of clinical specimens or transiently 
colonizing body surfaces and secretions ( 1- 4 ). It is much Jess 
fastidious than most other clinically important mycobacteria. 
The spectrum of human disease, which is usually oppor-
tunis tic. varies widely, and ranges from postt raumatic local 
cutaneous lesions to osteomyelitis, p ulmonary nodules, endo-
carditis. postsurgical sepsis and disseminated illness (3- 6). 
Cutaneous infections are the most frequently encountered 
lesions. T hey occur p rimarily as abscesses, which usually result 
from trauma, s11ch as with injections, following surgery, or 
after accidental injury (3- 5, 7. 8). M. abscessus cutaneous 
infect ion wi thout a history of preceding trauma developed in 
the immunocompromised patient described here. Diagnostic 
and therapeutic considerations are discussed. 
CASE REPO RT 
ln our patient. at the age of 51 years, breast cancer was diagnosed. 
which was treated surgicaUy followed by radiotherapy and adjuvant 
therapy with 5-fluouracil and tamoxifen. During the next 4 years, 
metastases in mediastinal lymph nodes, liver. and bones were dia-
gnosed and treated with radiotherapy, tamoxifcn and exemestane. 
Five years after her primary tumour, a cerebellar metastasis was 
diagnosed. for which she r.:ceived radiotherapy and dexamethasone 
in dosages up to 14 mgfday for 4 months. In addition and in view of 
progressive mediastinal disease. a first course of chemotherapy with 
cyclophosphamide. methotrexate and 5-Buouracil was given during 
this period. 
Ac11z Derm Venereol (STOck II ) 77 
Shortly after this course she was admitted because of increasing 
fatigue. loss of muscle strength and dyspnoea, which rendered her 
bedridden. Her treatment at this point stiiJ included dexamethasone 
1.5 mgfday. On physical examination. she had central adipositas, 
striae and several bematomes. There was no adenopathy. Multiple 
tender erythematous nodules on both upper legs and buttocks were 
observed, which bad developed during the previous weeks. 
During her 7-wcek hospital stay she received a second and third 
course of chemotherapy_ in a reduced dosage because of development 
of profound pancytopenia. One week after her admission, the patient 
developed a period of fever which lasted I month. for which no clear 
explanation was found. 
Results of routine laboratory examinations on admission included 
an ESR 27 rumfhr, hemoglobin of 8.2 mmolfl, and leukocytes 
0.8 x 109 I, with a normal distribution. 
Chest radiographs showed left hilar enlargement due to metastasis, 
some pleural effusion on the left and no infiltration or cavitation. 
Differentia l diagnosis of the skin lesions included paraneoplastic 
panniculitis, erythema nodosum. metastatic or infectious disease. 
Biopsy of the skin lesions showed a lobular granulocytic-monocytic 
mllammatory infiltrate with local necrosis but without granulomas. 
vasculitis or signs of malignancy. Under the presumptive diagnosis 
of paraneoplastic panniculitis (9). treatment with prednisone 
t40- 60 mgjd} was given. However. the number of lesions increased. 
After a short dismissal (on prednisone 20 mgjd}. the patient was 
readmitted, and more generalized skin lesions were observed, some 
ulcerating (Fig. 1 ). A new and deeper skin biopsy revealed essentially 
the same histology as previously, but in addition some histiocytary 
cells and some polynuclear giant cells of the Langerhans' type. A 
Ziehl Neelsen stain was performed and numerous acid-fast baciUi were 
~een in the necrotic areas (Fig. 2). Cultures were taken. The pulmonary 
X-ray was unchanged as compared to 2 months earlier. Puncture of 
the pleura fluid yielded a normal cytology, and a Ziehl Neelsen stain 
was negative. Urine culture for mycobacteria was negative. 
Examination of the eyes revealed no abnonnal ities. She was initially 
treated with isoniazide ( 300 mg/day), rifampicine( 600 mg/day), pyraz. 
inamide (2 g/day) , pyridoxine (20 mg/day) and ethambutol (2 g/day) 
for several weeks. and therapy with glucocorticosteroids was discon-
tinued, but the skin lesions progressed. Routine bacteriologic and 
fungal cultures revealed no superinfection. Cultures for mycobact-
eria were positive after 1 week. Successive determination yielded 
.'vi. abscessus. which was not sensitive in vitro to any tuberculostatic 
drug or to amikacin. ciprofloxacin and erythromycin, but which was 
sensitive to clarithromycin and clofaz.imine. Therefore. tuberculostatic 
therapy was stopped and oral therapy with clarithromycin (500 mg 
bid) and clofazimine (200 mg/48 h) was started. 
Her lesions regressed over the subsequent month, and cultures for 
mycobacteria taken 2 weeks after the stan of therapy were negattve. 
At th is point. deterioration of her clinical c.onctition, with comple1e 
bedridden hospita lization. made the patient express her wish to 
withdraw all medical therapy. and shortly afterwards she died. 
Although postmortem investigation was not allowed, her death was 
not considered due to direct complications of the M. abscessus 
infection. in view of the low vinllence of th is lvfl'coharterium and the 
response of the skin lesions to therapy_ -
DISCUSSION 
Nowadays, serious infections with normally apathogenic 
microorganisms represent an increasing problem, because host 
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Fig. I. Extensive ulcerating lesions on nates. 
Fig. 2. Ziehl Neelscn stain of biopsy with numerous acid-fast bacilli. 
defenses are compromised in a growing number of patients 
(e.g. due to cancer chemotherapy. immunosuppressive therapy 
and AIDS). Cutaneous lesions in this type of patient should 
alert the clinician not only to the possibility of noninfectious 
causes, such as malignancy, but also to the possibility of 
infect ion by opportunistic micro-organisms, including atypical 
mycobacteria. 
Tn irnmunocompromised patients, skin lesions due to 
1\f. abscessus can occur without a history of trauma. and 
generally present as persisting subcutaneous, sometimes tender 
nodules that may progress to ulcera, yielding purulent material. 
Regional lymphadenopathy and general symptoms like fever 
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and fatigue sometimes oc.cur ( 6, 8). The period of fever in our 
patient may be explained by the cutaneous infection. There is 
no evidence for person-to-person spread of atypical myco-
bacteria, although wound isolation is advised in cutaneous 
disease (1, 5, 10 ). 
Diagnosis involves histologic examination and culture for 
acid-fast micro-organisms of biopsy specimens. 
Histology may show a broad spectrum of possible inflam-
matory responses ( 4. 5. 8). Characteristic tuberculoid granu-
lomas sometimes occur, but more often there is a dimorphic 
inflammatory response showing both acute inflanunatioo and 
chronic inflammation with foreign body giant cells and/or 
Langerhans' cells. Necrosis is usually present, but it is rarely 
caseous. Results of Ziehl eelsen staining are usually, but not 
always, positive ( 5 ). When acid-fast stains are not performed 
or when the result is negative, the lesions may easily be 
misd iagnosed as erythema nodosum or as noninfectious pan-
niculitis ( 8, 9), as initially occurred in our patient. 
Definitive diagnosis depends on culture of the mycobacteria. 
Unfortunately. it is often delayed, not only because of the 
lack of familiarity with the atypical mycobacteria and the 
usually aspecific histology, but also because of the often slow 
initial growth on initial isolation (2 to 30 days). It is crucial 
to aseptically obtain cutaneous biopsy specimens, preferably 
not only from ulcera but also from intact subcutaneous lesions. 
Tuberculin PPD skin tests are usually negative in M. abscessus 
infections (7, 8, 11 ); therefore, specific antigens should be used 
(II, 12). 
Additional diagnostics to evaluate generalization include 
cultures of blood, urine and sputum. although M. abscessus 
may colonize respiratory secretions without a role in disease 
( I, 10). 
Antimicrobial therapy and/or surgery is sometimes necessury 
in immunocompetent patients and is usually indicated in 
immunosuppressed patients ( 10). Surgical debridement may 
yield good results but is difficult to realize in the ca~e of 
extensive lesions (5, 7, 8). Antimicrobial therapy is often 
difficult, since M. abscessus is usually resistant in vitro against 
all tuberculostatics. The micro-organism may be susceptible 
to agents commonly used for pyogenic bacterial infections. 
especially for clarithromycin, amikacin, cefoxitin and imip-
enem ( I, 3. 6. 13. 14 ). There are some studies reporting the 
efficacy of clofazimine on M. abscessus ( 15, 16). Selection of 
agents should be guided by results of in vitro susceptibility 
tests. 
Although monotherapy with clarithromycin has been 
described to produce good results without the development of 
resistance (6. 14. 17) , in mycobacterial infections, single-drug 
therapy should be avoided to reduce the emergence of drug 
resistance (5. 13, 14 ). Though 2-4 weeks of therapy is usually 
sufficient to resolve cutaneous lesions. 3 months' therapy is 
probably required to reduce relapse rates (I. 3, 4 ). 
Tn conclusion. delay of diagnosis of disease due to atypical 
mycobacteria often occurs. The case reported in this study 
illustrates this. Greuter knowledge of the clinical picture and 
risk factors, like immunosuppression, is necessary. 
Since atypical mycobacteria are ubiquitous. and the numbers 
of irnmunocompromised patients are rising, it is very likely 
that in the future infections by these pathogens will be 
encountered even more often. 
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